000 | 01309 a2200385 4500 | ||
---|---|---|---|
005 | 20250512031149.0 | ||
264 | 0 | _c19860324 | |
008 | 198603s 0 0 eng d | ||
022 | _a0361-5960 | ||
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aMitchell, E P | |
245 | 0 | 0 |
_aContributions of nitrosoureas to cancer treatment. _h[electronic resource] |
260 |
_bCancer treatment reports _cJan 1986 |
||
300 |
_a31-41 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Review | ||
650 | 0 | 4 |
_aAlkylating Agents _xtherapeutic use |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 | _aAntineoplastic Agents |
650 | 0 | 4 | _aAntineoplastic Combined Chemotherapy Protocols |
650 | 0 | 4 |
_aBone Marrow _xdrug effects |
650 | 0 | 4 |
_aCarcinoma, Small Cell _xdrug therapy |
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aDNA, Neoplasm _xmetabolism |
650 | 0 | 4 |
_aGastrointestinal Neoplasms _xdrug therapy |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aLeukemia L1210 _xdrug therapy |
650 | 0 | 4 |
_aLung Neoplasms _xtherapy |
650 | 0 | 4 |
_aLymphoma _xdrug therapy |
650 | 0 | 4 | _aMice |
650 | 0 | 4 |
_aNitrosourea Compounds _xmetabolism |
650 | 0 | 4 |
_aStreptozocin _xanalogs & derivatives |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aSchein, P S | |
773 | 0 |
_tCancer treatment reports _gvol. 70 _gno. 1 _gp. 31-41 |
|
999 |
_c3008437 _d3008437 |